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Abstract
Aims: Bacillithiol (BSH) is the major low-molecular-weight thiol of the human pathogen Staphylococcus aureus.
In this study, we used OxICAT and Voronoi redox treemaps to quantify hypochlorite-sensitive protein thiols in
S. aureus USA300 and analyzed the role of BSH in protein S-bacillithiolation.
Results: The OxICAT analyses enabled the quantification of 228 Cys residues in the redox proteome of S. aureus
USA300. Hypochlorite stress resulted in >10% increased oxidation of 58 Cys residues (25.4%) in the thiol redox
proteome. Among the highly oxidized sodium hypochlorite (NaOCl)-sensitive proteins are five S-bacillithiolated
proteins (Gap, AldA, GuaB, RpmJ, and PpaC). The glyceraldehyde-3-phosphate (G3P) dehydrogenase Gap rep-
resents the most abundant S-bacillithiolated protein contributing 4% to the total Cys proteome. The active site
Cys151 of Gap was very sensitive to overoxidation and irreversible inactivation by hydrogen peroxide (H2O2) or
NaOCl in vitro. Treatment with H2O2 orNaOCl in the presence of BSH resulted in reversible Gap inactivation due to
S-bacillithiolation, which could be regenerated by the bacilliredoxin Brx (SAUSA300_1321) in vitro. Molecular
docking was used to model the S-bacillithiolated Gap active site, suggesting that formation of the BSH mixed
disulfide does not require major structural changes.
Conclusion and Innovation: Using OxICAT analyses, we identified 58 novel NaOCl-sensitive proteins in the
pathogen S. aureus that could play protective roles against the host immune defense and include the glycolyticGap as
major target for S-bacillithiolation. S-bacillithiolation of Gap did not require structural changes, but efficiently
functions in redox regulation and protection of the active site against irreversible overoxidation in S. aureus.
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Introduction
Staphylococcus aureus is a common commensal bac-terium that colonizes the anterior nares and the skin of one
quarter of the human population without causing symptoms of
infections (22). However, S. aureus can also cause infections
ranging from local skin or soft tissue infections to life-
threatening diseases, such as septicemia, endocarditis, and
necrotizing pneumonia, when the pathogen enters the blood-
stream (2, 8, 53). Many nosocomial infections are caused by
multiple antibiotic-resistant strains, such as methicillin-resistant
S. aureus (MRSA) isolates (50). Moreover, new community-
acquiredMRSA strains are emerging quicklywith other strains
that are resistant to the last resort of antibiotics, such as van-
comycin (22). Thus, to understand the adaptation of the path-
ogen to the host defense, it is of utmost importance to identify
new drug targets for the treatment of MRSA infections.
The success of S. aureus as a leading pathogen is caused by
high diversity of different virulence factors, such as toxins,
proteases, lipases, and superantigens, as well as efficient
protection mechanisms against the host immune defense
during invasion. During infections, S. aureus has to cope with
the oxidative burst of activated macrophages and neutrophils,
including reactive oxygen and nitrogen species (ROS, RNS)
and the strong oxidant hypochlorous acid (HOCl) (75, 76).
HOCl is produced in neutrophils by the enzyme myeloper-
oxidase (MPO) from hydrogen peroxide (H2O2) and chloride
(44). The involvement of HOCl as prime mechanism for
oxidative killing of S. aureus by neutrophils has been shown
using MPO inhibitors (29). Moreover, killing of many bac-
teria by isolated neutrophils is strongly inhibited in the ab-
sence of MPO (44).
S. aureus uses several redox-sensing virulence regulators,
such as SarA and the MarR/OhrR-type regulators, MgrA and
SarZ, for defense against oxidative stress. These control large
regulons of virulence factors, antibiotic resistance determi-
nants, and ROS detoxification enzymes (11–13, 35). MgrA
and SarZ are both single CysMarR/OhrR-type repressors that
sense and respond to ROS via thiol-based redox switches and
by Cys phosphorylation (63, 70). In addition, S. aureus uses
the low-molecular-weight (LMW) thiol bacillithiol (BSH,
Cys-GlcNAc-Mal) to maintain the reduced state of the
cytoplasm. BSH plays an important role in detoxification
of redox-active compounds in S. aureus since bshA mu-
tants displayed increased sensitivities to ROS, hypochlorite,
electrophiles, and the antibiotic fosfomycin (52, 64, 65).
Moreover, BSH mediates protection under infection-like
conditions as shown in phagocytosis assays using human
macrophages (64, 65). Apart from BSH, also CoenzymeA
(CoASH) and cysteine are found as abundant alternative
LMW thiols in S. aureus cells (58).
Under hypochlorite stress, we have shown that BSH is
also used for S-thiolation of redox-sensitive Cys residues
and forms mixed disulfides with proteins that are termed
as S-bacillithiolation. S-bacillithiolation protects protein
thiols against overoxidation to sulfonic acids and is an im-
portant redox regulatory device in Firmicutes analogous to S-
glutathionylation in eukaryotes (15, 16, 47, 52). The presence
of CoASH and cysteine as LMW thiols suggests that alter-
native S-thiolations are also possible in S. aureus, such as S-
cysteinylation or CoASH mixed disulfides. In support of this
notion, S. aureus encodes a CoASH disulfide reductase
(Cdr) that functions in reduction of CoASH mixed protein
disulfides (55).
Using shotgun proteomics, we have previously identified 54
S-bacillithiolated proteins in different Bacillus species and
Staphylococcus carnosus (16). Among these are eight con-
served S-bacillithiolated proteins, such as the methionine
synthase MetE, the inorganic pyrophosphatase PpaC, and the
inosine-5¢-monophosphate (IMP) dehydrogenase GuaB. The
glutaredoxin-like YphP protein of the UPF0403 family was
also S-bacillithiolated in Bacillus subtilis in vivo at its CGC
active site motif (15). YphP and its paralog YqiW were re-
named as BrxA and BrxB based on their function as bacilli-
redoxins in the reduction of S-bacillithiolated OhrR and MetE
in vitro (24). Reduction of S-bacillithiolated proteins leads to
Brx-SSB formation, which requires BSH and a still unknown
BSSB reductase for recycling (24, 25, 31, 52). We have re-
cently fused the YphP homolog (Brx) of S. aureus USA300
(SAUSA300_1321) to roGFP2 to construct a dynamic bio-
sensor to monitor BSH redox potential changes in vivo (51).
Brx-roGFP2 was highly specific to recognize BSSB, which
confirms the role of Brx as bacilliredoxin also in S. aureus.
The physiological role of S-bacillithiolation in redox
regulation has been demonstrated for the redox-sensing
OhrR repressor and the methionine synthase MetE under
hypochlorite stress in B. subtilis. S-bacillithiolation of MetE
in its active site Zn center leads to its inactivation and sub-
sequent methionine auxotrophy (15). The DNA-binding
activity of the organic hydroperoxide repressor, OhrR, is
inhibited by S-bacillithiolation under sodium hypochlorite
(NaOCl) and cumene hydroperoxide stress, which results in
the expression of the OhrA peroxiredoxin as ROS protection
mechanism (15, 47).
However, the targets for S-bacillithiolation or reversible
thiol oxidation under hypochlorite stress are unknown in the
major pathogen S. aureus, which could provide leads in drug
design to treat MRSA infections. In this study, we have com-
bined the quantitative redox proteomic approach OxICAT (9,
48, 49) and shotgun proteomics to quantify NaOCl-sensitive
proteins and to identify S-bacillithiolated proteins in S. aureus
USA300. We found that 25% protein thiols showed >10%
increased oxidation under NaOCl stress. The glycolytic Gap
was identified as themost abundantS-bacillithiolated protein in
S. aureus. Our results document that S-bacillithiolation pro-
tects the active site against overoxidation and inhibits Gap
activity in vitro.
Innovation
Using quantitative redox proteomics, 58 redox-
sensitive protein thiols were identified in the methicillin-
resistant Staphylococcus aureus strain USA300 that
showed >10% increased oxidation under NaOCl stress.
The glyceraldehyde-3-phosphate dehydrogenase Gap
was identified as most abundant target for thiol oxidation
and represents the major S-bacillithiolated protein in S.
aureus cells. Molecular docking of bacillithiol (BSH)
into the active site suggests that S-bacillithiolation does
not require major structural changes. Finally, our bio-
chemical assays confirm that S-bacillithiolation effi-
ciently protects the Gap active site against overoxidation
by H2O2 and NaOCl and inhibits Gap activity, which can
be reversed by the bacilliredoxin Brx in vitro.
PROTEIN S-BACILLITHIOLATION CONTROLS GAP ACTIVITY 411
Results
Identification of 58 NaOCl-sensitive proteins
using the quantitative redox proteomic approach
OxICAT in S. aureus USA300
We were interested to study the role of BSH for S-
bacillithiolation and the global thiol oxidation state under
hypochlorite stress in the major pathogen S. aureus. Thus, we
performed a quantitative thiol redox proteomic approach
based on OxICAT (48, 49) and analyzed the percentages of
thiol oxidation levels in S. aureus USA300 in response to
150lMNaOCl stress, as determined previously (51). OxICAT
is based on the differential thiol labeling of reduced Cys res-
idues with light isotope-coded affinity tag (12C-ICAT), fol-
lowed by reduction of reversible thiol oxidation (e.g., protein
disulfides and S-thiolation) with Tris (2-carboxyethyl) phos-
phine (TCEP) and subsequent labeling of previously oxidized
thiols with heavy 13C-ICAT reagent (48). Light and heavy
ICAT-labeled peptide pairs show a mass difference of 9 Da
after separation using mass spectrometry (MS). The quantifi-
cation of the percentage of thiol oxidation for each Cys peptide
is based on the calculation of the intensity of the heavy ICAT-
labeled Cys peptide in relation to the total intensity of the light
and heavy ICAT-labeled Cys peptides.
The OxICAT analysis enabled the quantification of the
percentages of reversible thiol oxidation for 228 Cys peptides
in the thiol redox proteome of S. aureus USA300 (Supple-
mentary Table S1; Supplementary Data; Supplementary Data
are available online at www.liebertpub.com/ars). The per-
centages of thiol oxidation were color coded and visualized in
Voronoi redox treemaps according to the TIGRfam classifi-
cation of S. aureus USA300 (Fig. 1).
In untreated S. aureus cells, we identified 193 Cys residues
(84.6%) with a thiol oxidation level of <25%, including 107
Cys residues (46.9%) with <10% oxidation, indicating that
the majority of thiols are in a reduced state (Tables 1 and 2;
Supplementary Table S1). Only 35 Cys residues (15.3%)
showed basal-level oxidation of >25% in the control. These
FIG. 1. Percentages of thiol oxidation for 228 Cys peptides that are identified in Staphylococcus aureus USA300 and
visualized using Voronoi redox treemaps. The percentages of thiol oxidation of 228 Cys residues that are identified using
OxICAT in S. aureus USA300 in the control (A) and 30min after exposure to 150 lM NaOCl stress (B) are visualized using
Voronoi redox treemaps. The gray–red color gradient denotes 0–100% oxidation. The Voronoi redox treemap in (C) shows
the percentages of oxidation changes under NaOCl stress using a blue–red color gradient ranging from -75% to +75%
oxidation. The treemap in (D) serves as the legend showing the functional classifications of proteins. The treemaps are
generated using the Paver software (Decodon) based on the OxICAT data presented in Supplementary Tables S1 and
proteins were classified according to the S. aureus USA300 TIGRfam annotation. NaOCl, sodium hypochlorite.
412 IMBER ET AL.
basal-level oxidized proteins include predicted redox-sensitive
proteins (21), such as the thiol peroxidase Tpx, the alkyl hy-
droperoxide reductase large subunit AhpF, the arsenate re-
ductase ArsC1, and the thioredoxin reductase TrxB1. Tpx and
AhpCF were previously found as basal-level oxidized in the
redox proteomes of Escherichia coli and Bacillus species (16,
48). Tpx was also S-mycothiolated in Corynebacterium glu-
tamicum at the conserved active site Cys60 (14). In addition,
the topoisomerase TopA and the DnaJ chaperone are basal-
level oxidized at their Zn-binding Cys residues.
To discover novel NaOCl-sensitive proteins, we analyzed
the percentages of thiol oxidation levels under NaOCl
stress and its oxidation increase using OxICAT (Fig. 1 and
Tables 2; Supplementary Table S1). The OxICAT approach
enabled the identification of 58 NaOCl-sensitive Cys residues
(25.4%) with >10% increased oxidation, including 19 Cys
residues with 20–30% oxidation change under NaOCl stress
(Tables 1 and 2 and Supplementary Table S1). Several
NaOCl-sensitive proteins have antioxidant functions, such as
the AhpCF peroxiredoxins, the thioredoxin reductase TrxB1,
and the arsenate reductase ArsC. Furthermore, interesting
proteins are the nitric oxide synthase (USA300HOU_1916)
and the CoASH disulfide reductase Cdr (USA300HOU_
0929), the latter is oxidized at the conserved Cys16. Apart
from Cdr, the putative BSH disulfide reductase YpdA
(USA300GOU_1417) was oxidized at the same conserved
Cys14, but its oxidation is not increased under NaOCl stress
(Supplementary Table S1). Moreover, we observed a slightly
increased oxidation of the deacetylase BshB2 involved BSH
biosynthesis and of the bacilliredoxin YqiW (BrxB) under
NaOCl stress. The oxidation of Cdr, YpdA, BshB2, and BrxB
could indicate increased S-bacillithiolation and CoASH
mixed protein disulfides under NaOCl stress.
NaOCl-sensitive proteins are often oxidized in CxxC
motifs and at conserved Zn-binding sites. Examples for Zn
redox switches are the Zn-containing alcohol dehydrogenase
Adh (USA300HOU_0610), the ribosomal proteins RpmG3
(USA300HOU_1553), and RpmJ (USA300HOU_2218). Zn-
containing ribosomal proteins share three to four Cys residues
that are suggested to serve as reservoir for Zn storage (54). As
another Zn redox switch, we identified the ferric uptake
repressor Fur that showed 16.6% increased oxidation at its
Zn-binding site at Cys 140 and Cys143 under NaOCl stress
(Tables 2; Supplementary Table S1; Figs. 1–2). Fur contains
two CxxC motifs that form a structural Cys4:Zn site and are
required for stability. In addition, two regulatory iron-
binding sites are present in Fur (32). FurA of Anabaena was
described as redox switch under oxidative stress and Cys101
in the CxxC motif is essential for iron-sensing and DNA-
binding activity (7).
The copper chaperone CopZ was 19.8% oxidized in its
CxxC motif that is required for Cu binding (67). The inter-
action of the B. subtilis CopZ homolog with BSH has been
recently studied leading to the formation of S-bacillithiolated
apo-CopZ and Cu(i)-bound forms of CopZ (42). In addition,
NaOCl-sensitive Cys residues often coordinate FeS clusters
or function in FeS cluster biogenesis. The FeS cluster scaf-
fold protein NifU showed 26% increased oxidation at Cys41
that binds the FeS cluster during the assembly. The cysteine
desulfurase NifS exhibits 20.6% higher oxidation levels at
the catalytic Cys371 that forms the persulfide with the sulfur
released during cysteine desulfuration (5). In addition, the
FeS cluster assembly protein SufB is oxidized in its FeS
cluster binding Cys302. It is interesting to note that the nifS-
nifU-sufB genes are cotranscribed in an operon.
As NaOCl-sensing redox regulators, the MarR/OhrR
family repressors, MgrA and SarZ (USA300HOU_0709 and
USA300HOU_2368), were identified that showed 10.5% and
6.5% increased oxidation levels under NaOCl stress at their
redox-sensing single Cys (Fig. 2). The DNA-binding activity
of MgrA and SarZ was inhibited by S-thiolation using a
synthetic thiol in vitro (11, 13, 35). In this study, increased
oxidation of MgrA and SarZ was found in S. aureus under
NaOCl stress, indicating that both could be redox controlled
by S-bacillithiolation analogous to OhrR of B. subtilis (47).
OhrR and SarZ both control a homologous ohrA peroxir-
edoxin gene that confers resistance to organic hydroperox-
ides and NaOCl in B. subtilis (13). Northern blot analyses
revealed increased transcription of ohrA under NaOCl stress,
indicating that SarZ oxidation leads to its inactivation and
derepression of ohrA transcription (Fig. 3). We further noted
the 15% increased oxidation of the virulence factor and se-
cretory antigen SsaA2 at its conserved single Cys171 under
NaOCl stress. The homologous SceB precursor (Sca_1790)
of S. carnosus was previously S-bacillithiolated at the con-
served Cys in NaOCl-treated cells (16). Thus, SsaA2 is most
likely also S-bacillithiolated in S. aureus.
The NaOCl-sensitive proteins of S. aureus include many
metabolic enzymes that function in energy metabolism and
in different biosynthesis pathways for amino acids, fatty
acids, nucleotides, and cofactors. NaOCl-sensitive en-
zymes involved in energy metabolism include the glyco-
lytic glyceraldehyde-3-phosphate (G3P) dehydrogenase
Gap and phosphofructokinase PfkA (USA300HOU_1685),
the alcohol dehydrogenase Adh, the aldehyde dehydrogenase
AldA (USA300HOU_2110), the formate dehydrogenase FdhA
(USA300HOU_2291), and the malate dehydrogenase Mqo
(USA300HOU_2348). Gap and AldA both showed the highest
oxidation increase of 29% and 26%under NaOCl stress at their
Table 1. Overview of % Thiol Oxidation
of 228 Cys Residues in the Redox Proteome
of Staphylococcus aureus
228 Cys residues <25% (<10%) >25% (>40%)
% Thiol oxidation
Control
193 (107) 35 (15)
84.6% (46.9%) 15.3% (6.6%)
% Thiol oxidation
NaOCl
159 (35) 69 (27)
69.7% (15.3%) 30.2% (11.8%)
<10% >10% (20–30%)
% Thiol oxidation
increase
(NaOCl/Control)
170 58 (19)
74.6% 25.4% (8.3%)
Overview of % thiol oxidation of 228 Cys peptides identified in the
redox proteome of the S. aureus USA300 under control and NaOCl
stress, as revealed by OxICAT. All reduced Cys peptides have an
oxidation degree of <25% that include those with <10% oxidation,
shown in parenthesis. Oxidized Cys peptides have an oxidation degree
of >25%. The % thiol oxidation increase includes Cys peptides with
no significant increased oxidation (<10%) and those with >10%
increased oxidation in response to NaOCl stress compared with the
control. The % thiol-oxidation and % thiol-oxidation increase and
related Cys numbers are shown in bold-faced. The percentage of Cys
numbers in relation to all Cys residues is shown in non-bold faced.
NaOCl, sodium hypochlorite.
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catalytic active sites at Cys151 and Cys279, respectively.
Furthermore, the IMP dehydrogenase GuaB and the purine
nucleosidase USA300HOU_2265 both displayed 25% in-
creased oxidation under NaOCl stress (Tables 2; Supplemen-
tary Table S1).
Among the cell wall biosynthesis enzymes, the alanine
racemase Alr2 (USA300HOU_2065) and the UDP-N-
acetylglucosamine 1-carboxyvinyltransferase MurZ (USA
300HOU_2112) were identified as NaOCl-sensitive pro-
teins. The glucose-inhibited division proteinMnmG showed
20.8% increased oxidation under NaOCl stress. Many
aminoacyl-tRNA synthetases were strongly oxidized under
NaOCl stress. We detected 18–24% higher oxidation levels
for the histidine- and phenylalanine tRNA ligases (HisS and
PheT2) and for the queuine tRNA ribosyltransferase (Tgt)
under NaOCl stress.
Five S-bacillithiolated proteins were identified
using shotgun proteomics in S. aureus, including
the glycolytic Gap as major target
We used the previously applied shotgun proteomic ap-
proach for identification of S-bacillithiolated proteins under
nonreducing conditions based on the 396 Da mass increase at
Cys residues (16). Five S-bacillithiolated proteins were
identified in NaOCl-treated cells of S. aureus USA300, in-
cluding Gap, AldA, GuaB, RpmJ, and the manganese-
dependent inorganic pyrophosphatase PpaC (Table 3; Sup-
plementary Fig. S1). GuaB was S-bacillithiolated at its active
site Cys307, which forms the thioimidate intermediate with
the substrate and is S-thiolated also in other gram-positive
bacteria (Table 3; Supplementary Fig. S1).
Gap and AldA were S-bacillithiolated at their catalytic
active sites at Cys151 and Cys279, respectively (Fig. 2 and
Table 3; Supplementary Fig. S1). The AldA homolog of S.
carnosus was previously found S-bacillithiolated at Cys279
(16). The active site Cys of Gap is a conserved target for S-
glutathionylation in eukaryotic Gap homologs. Cys151 of
Gap showed 29.5% oxidation increase under NaOCl stress in
the OxICAT analysis, which is reflected also by the mass
spectra of the ICAT-labeled Cys151-peptides (Fig. 4A).
Nonreducing BSH-specific Western blots further identified
that Gap is the most abundant S-bacillithiolated protein under
hypochlorite stress based on the size and supported by theMS
results (Fig. 4B; Supplementary Fig. S1). Gap-SSB was de-
tected in the S. aureusUSA300 and COL strains, but is absent
in the bshA mutant as expected.
Gap contributes as most abundant Cys protein
with 4% to the total Cys proteome
We were further interested in the contribution of Gap and
other S-bacillithiolated proteins to the total Cys proteome of
S. aureus. S. aureus USA300 encodes for 2694 proteins.
These include 1864 proteins with 4935 Cys residues, indi-
cating that the Cys content is 0.64% in the theoretical pro-
teome (Supplementary Fig. S2A, B). Using shotgun
proteomics, the spectral protein abundance for 600 proteins,
FIG. 2. Close-ups of the redox treemaps of S. aureus USA300 showing S-bacillithiolated enzymes and redox
regulators (SarZ, MgrA, and Fur). Enlarged sections of the redox treemaps are shown that include the identified S-
bacillithiolated proteins (Gap, AldA, GuaB, RpmJ) and NaOCl-sensitive redox-sensing regulators (MgrA, SarZ, and Fur).
The close-ups show the percentages of thiol oxidation under control, NaOCl stress, and the percentage of oxidation change
under NaOCl stress versus control as revealed in Figure 1 using the same color gradient. The symbol * denotes conserved Cys.
FIG. 3. Northern blot analysis showing transcriptional induction of the SarZ-regulated ohrA gene (USA300-
HOU_0835) under NaOCl stress. RNA was isolated from S. aureus USA300 grown in Belitsky minimal medium under
control and NaOCl stress conditions and subjected to Northern blot analysis for ohrA (USA300HOU_0835) transcription.
Transcription of ohrA is upregulated due to SarZ thiol oxidation and inactivation under NaOCl stress as revealed by
OxICAT analysis in vivo.
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including 398 Cys-containing proteins, was determined in the
proteome of S. aureusUSA300 (Supplementary Table S2 and
Supplementary Fig. S2C). The protein abundance in the
proteome is visualized using Voronoi treemaps (Fig. 5). The
cell size corresponds to the spectral protein abundance and
the color code denotes the numbers of Cys residues. The
majority of 226 Cys proteins identified in the proteome
possess only 1–2 Cys residues. However, there are also six
proteins with >10 Cys residues. The most Cys-rich protein
was identified as the formate dehydrogenase FdhA that
contains 26 Cys residues coordinating several FeS clusters.
Based on their spectral abundance, we identified 50 abundant
Cys-containing proteins that contribute to 60% of the total S.
aureus Cys proteome (Supplementary Fig. S2C). The redox
state for the majority of these Cys peptides was quantified
using the OxICAT approach (Supplementary Table S1). The
Cys abundance treemap also shows that many ribosomal
proteins and the pyruvate dehydrogenase do not possess Cys
residues (Fig. 5).
The S-bacillithiolated Gap was identified among the most
abundant Cys-containing proteins and contributes with 4% of
the total Cys proteome (Supplementary Fig. S2C). This
indicates that Gap makes the major contribution to the
S-bacillithiolome of S. aureus as visualized also by the BSH
Western blots. The other S-bacillithiolated proteins, AldA,
RpmJ, GuaB, and PpaC, are less abundant and make with
0.1–0.7% of Cys abundance only a minor contribution to the
total Cys proteome (Supplementary Table S2).
H2O2 and NaOCl-induced inactivation pathways
of Gap in S. aureus due to overoxidation
and S-bacillithiolation in vitro
The active site of Gap is usually present in a highly con-
served CTTNC motif in different organisms (Supplementary
Fig. S3). However, in the S. aureus Gap, the second cysteine
is replaced by a serine. The identification of S-bacillithiolated
Gap under hypochlorite stress was intriguing since a previous
proteomic study has shown that Gap of S. aureus is very
sensitive to overoxidation to the sulfonic acid form in the
presence of 100mM H2O2 in vivo (73). In another proteomic
study, Gap was identified as reversibly oxidized by 10mM
H2O2 in S. aureus (19). Thus, we were interested to study the
inhibition of Gap activity in vitro due to overoxidation and
S-bacillithiolation under both H2O2 and NaOCl stresses.
Gap of S. aureus was purified as His-tagged protein from
E. coli. The inhibition of Gap activity by increasing H2O2
concentrations was monitored spectrophotometrically with
G3P as substrate in the presence of NAD+. The remaining
Gap activity was determined by nicotinamide adenine dinu-
cleotide (NADH) generation as absorbance change at 340 nm
during the slope in the reaction, as described previously (61).
Treatment of Gap with 100 lMH2O2 leads to a 50% decrease
in Gap activity, while exposure to 1–10mM H2O2 resulted in
complete enzyme inactivation (Fig. 6A). Inactivation of Gap
with 1–10mM H2O2 alone was irreversible due to over-
oxidation since Gap activity could be not restored with
10mM dithiothreitol (DTT) (Fig. 6C). To investigate whether
S-bacillithiolation can protect the enzyme against irreversible
overoxidation, Gap was pretreated with 10-fold molar excess
of BSH before H2O2 exposure. Gap activity was already 90%
inhibited after oxidation with 100 lMH2O2 in the presence of
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FIG.4. OxICATanalysis revealeda29%increasedoxidationof theGapCys151peptide (A)andGapwas identifiedasmost
abundant S-bacillithiolated protein in S. aureus underNaOCl stress as shown byBSH-specificWestern blot analysis (B). (A)
The OxICATmass spectrometry results are shown for the Gap Cys151 peptide in S. aureusUSA300 under control and 30min after
NaOCl stress. The reduced Gap Cys151 peptides in the cell extract are labeled with light 12C-ICAT, followed by reduction of all
reversible thiol oxidation, including the S-bacillithiolated Cys151 peptides and subsequent labeling of previously oxidized Cys151
peptide by heavy 13C-ICAT reagent. According to the quantification by the MaxQuant software, the Cys151 peptide was 8.3%
oxidized in the control and its oxidation level increased to 37.7% under NaOCl stress. (B)Nonreducing BSH-specificWestern blot
analysis identified Gap as most abundant S-bacillithiolated protein in S. aureusUSA300 and COL strains under NaOCl stress. Two
independent biological replicates are shown for S. aureusCOL denoted as COL-1 and COL-2. Gap is S-bacillithiolated at the active
site Cys151 under NaOCl stress as revealed by subsequent LC-MS/MS analysis (Supplementary Fig. S1A). BSH, bacillithiol;
LC-MS/MS, liquid chromatography tandem mass spectry.
FIG. 5. Voronoi treemaps visualize Gap as the most abundant Cys protein in the total Cys proteome of S. aureus
USA300. The treemap legend (left) indicates the classification of the S. aureus USA300 proteome into functional categories
according to TIGRfam annotations. The cell size corresponds to the spectral counts of each protein identified in the proteome of
S. aureus USA300 and classified according to TIGRfam. The Cys-containing proteins are color coded using a yellow–red color
gradient based on their numbers of Cys residues (Supplementary Table S2). Proteins without Cys residues are displayed in gray.
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BSH, while treatment with 100lMH2O2 alone only led to 50%
decreased activity (Fig. 6A, B). Gap inactivation with H2O2 and
BSH was caused by reversible S-bacillithiolation since DTT
reduction resulted in recovery of Gap activity (Fig. 6C–E;
Supplementary Fig. S9). These results support that the Gap ac-
tive site is highly sensitive to overoxidation, which can be pre-
vented by S-bacillithiolation in the presence of H2O2 and BSH.
Next,we determined the time-dependentGap inactivation by
both H2O2-dependent oxidation pathways (Supplementary
Fig. S4). Gap was treated with 1mM H2O2 on ice with or
without BSH and the remaining Gap activity was determined
after different times of H2O2-dependent overoxidation and
S-bacillithiolation. The Gap activity assays revealed that both
S-bacillithiolation and overoxidation lead to 80% enzyme in-
hibition after 7.5min of H2O2 treatment (Supplementary
Fig. S4A). In addition, we analyzed the time course for the
detection of Gap-SSB or the overoxidized Cys151 under H2O2
treatment with or without BSH using BSH-specific Western
FIG. 6. Inactivation of Gap of S. aureus in response to H2O2 in vitro. (A, B) Reduced Gap (40 lM) was oxidized with
100 lM, 1, and 10mM H2O2 for 5min in the absence (A) or presence of 10-molar excess of BSH (400lM) (B) in reaction
buffer (100mM Tris HCl, 1.35mM EDTA, pH 8.0). The remaining Gap activity was measured in the presence of G3P and
NAD+ spectrophotometrically, following NADH production at 340 nm. The Gap activity was calculated as absorbance
change from the slope of the reaction in the first 80 s, as described in the Materials and Methods section. (C) To assess the
reversibility of Gap inactivation by H2O2, Gap was treated with 1 and 10mM H2O2 alone or with H2O2 and BSH, followed
by reduction with 10mM DTT. (D) Schematic showing the irreversible inhibition of Gap activity due to overoxidation of
the active site Cys with H2O2 alone, while Gap activity was reversibly inhibited with H2O2 and BSH due to S-
bacillithiolation. (E) S-bacillithiolation of Gap in the presence of 10mM H2O2 and BSH was confirmed using a BSH-
specific Western blot analysis before and after subsequent DTT reduction. DTT, dithiothreitol; EDTA, ethylenediamine-
tetraacetic acid; G3P, glyceraldehyde-3-phosphate; H2O2, hydrogen peroxide.
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blots or MS, respectively. The MS results identified the over-
oxidized Cys151 sulfonic acid (Cys151-SO3H) after 1min of
H2O2 treatment (Supplementary Fig. S5). The S-bacillithiolated
Gap could be also detected after 1min of treatment with BSH
and H2O2 (Supplementary Figs. S4B and S9). These results
suggest that overoxidation and S-bacillithiolation occur at
similar rates under H2O2 treatment in vitro. However, the Gap
activity assays after treatment with different H2O2 concentra-
tions indicate that Gap inhibition is faster with 100lMH2O2 in
the presence of BSH comparedwith 100lMH2O2 alone, which
only leads to 50% enzyme inhibition (Fig. 6A, B). Thus, S-
bacillithiolation of Cys151 by H2O2 in the presence of BSH
serves to protect the active site against overoxidation.
Since S-bacillithiolation of Gap was observed under
NaOCl stress in vivo, we studied the dose-dependent Gap
inactivation by NaOCl with or without prior exposure to BSH
(Fig. 7). Treatment of Gap with 100–500lM NaOCl led to
50–75% inhibition of Gap activity. Pretreatment of Gap with
BSH before exposure to 100lM NaOCl resulted in 70% ac-
tivity decrease. Gap was fully inactivated with 1mM NaOCl
in the absence or presence of BSH. Treatment of Gap with
1mMNaOCl alone resulted in irreversible inactivation due to
overoxidation since Gap activity could be not restored using
DTT. In the presence of BSH,Gap inactivation byNaOClwas
caused by reversible S-bacillithiolation since 85% Gap ac-
tivity could be restored by DTT reduction (Fig. 7C, D). Next,
we studied the time course for NaOCl-induced overoxidation
and S-bacillithiolation pathways in the presence of 1mM
NaOCl. The Gap activity assays with or without BSH showed
that Gap inhibition is faster with BSH and NaOCl compared
with NaOCl alone (Supplementary Fig. S6). These results
indicate that S-bacillithiolation can efficiently prevent over-
oxidation of the Gap active site under NaOCl in vitro, sup-
porting our in vivo finding.
FIG. 7. Inactivation of Gap of S. aureus
in response to NaOCl in vitro. (A, B) Re-
ducedGapwas treatedwith 0.1–1mMNaOCl
for 5minwithout (A) or with 10-molar excess
of BSH (B) in reaction buffer (100mM Tris
HCl, 1.35mM EDTA, pH 8.0). The remain-
ing Gap activity was measured spectropho-
tometrically, following NADH production at
340 nm. The Gap activity was calculated as
absorbance change from the slope of the re-
action in the first 80 s, as described in the
Materials and Methods section. (C) To ana-
lyze the reversibility of Gap inactivation
by NaOCl, Gap was inactivated with 1mM
NaOCl in the absence or presence of BSH,
followed by DTT reduction. Gap activity
was irreversibly inhibited after treatment
with NaOCl due to overoxidation since Gap
activity could be not restored by DTT. In the
presence of NaOCl and BSH, Gap was re-
versibly inactivated due to S-bacillithiolation
since DTT reduction resulted in 85% recovery
of Gap activity. (D) Schematic showing that
NaOCl leads to the transient sulfenylchloride
formation as unstable intermediate that reacts
further with BSH to form S-bacillithiolated
Gap. In the absenceofBSH,Gap-SCl is quickly
overoxidized resulting in irreversible inhibition
of Gap activity in vitro.
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Regeneration of S-bacillithiolated Gap
using the bacilliredoxin Brx (SAUSA300_1321) in vitro
The reversal of S-bacillithiolation was shown to require the
glutaredoxin-like bacilliredoxins, YphP (BrxA) and YqiW
(BrxB), in B. subtilis (24). Using a Brx-roGFP2 biosensor, we
demonstrated recently that the YphP homolog of S. aureus
(SAUSA300_1321 or Brx) is highly specific as bacilliredoxin
to recognize BSSB (51). Thus, Gap activity was measured
after debacillithiolation of Gap-SSB with Brx and Brx Cys
mutant proteins (BrxCGA, BrxAGC) and G3P oxidation was
followed by NADH production as absorbance change at
340 nm (Fig. 8A). Gap activity could be restored to 70% and
60% during debacillithiolation with Brx and the BrxCGA re-
solving Cys mutant in vitro, respectively. However, Gap ac-
tivity was only 25% recovered with the BrxAGC active site
mutant protein supporting the specificity of the Brx active site
for the attack of BSH mixed disulfide. Debacillithiolation of
Gap-SSB by Brx and the BrxCGA mutant was verified in
BSH-specificWestern blots (Fig. 8B; Supplementary Fig. S9).
These results indicate that S-bacillithiolation of Gap functions
in protection and redox regulation of the active site Cys and
can be reversed by the bacilliredoxin Brx in vitro (Fig. 8C).
Structural features of the Gap active site
during overoxidation and S-bacillithiolation
We were interested in structural changes of Gap after
overoxidation and S-bacillithiolation. The crystals of H2O2-
treated overoxidized Gap diffracted X-rays to 2.6 A˚ resolu-
tion and belonged to the P212121 space group. Previously,
several crystal structures of the Gap holo- and apoenzyme
have been reported with the protein always crystallized in the
P21 space group (57). The structure of the overoxidized Gap
contains four monomers in an asymmetric unit, each con-
sisting of the NAD+-binding domain (residues 1–150) and the
FIG. 8. Recycling of S-bacillithiolated Gap requires the bacilliredoxin Brx in vitro. (A) Gap activity is reversibly
inhibited by S-bacillithiolation in vitro and can be restored by reduction using the bacilliredoxin Brx (SAUSA300_1321).
Debacillithiolation required the Brx active site Cys. The BrxAGC mutant showed weak activity to reduce Gap-SSB, while
the Brx resolving Cys mutant (BrxCGA) could restore Gap activity similar to the wild-type Brx protein. S-bacillithiolated
Gap was generated in vitro by treatment of 25 lM Gap with 2.5mM H2O2 in the presence of 250 lM BSH. For deba-
cillithiolation, 2.5 lM Gap-SSB was incubated with 12.5 lM Brx, BrxAGC, and BrxAGC proteins for 30min. Gap activity
was measured after addition of G3P and NAD+ by spectrophotometric monitoring of NADH generation at 340 nm. (B) The
level of debacillithiolation of Gap-SSB in vitro by Brx and BrxCys mutant proteins was monitored using nonreducing BSH-
specific Western blot analysis. The SDS-PAGE is shown as loading control (right). The numbers 1–5 shown in the BSH
Western blot and in the SDS-PAGE refer to the legend shown in (A). (C) Schematic for the reduction of S-bacillithiolated
Gap using the bacilliredoxin Brx. SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
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catalytic domain (residues 151–336) (57) (Supplementary
Fig. S7A). The overall fold of overoxidized Gap is almost
identical to previously reported reduced Gap structures, with
only slight conformational differences observed in the loop
regions comprising residues 59–72, 75–90, and 111–118. The
root-mean square deviation after global superposition of
overoxidized Gap with the holo- (PDB code: 3LVF) or
apoenzyme (PDB code: 3LC7) was 1.01 and 1.11 A˚, re-
spectively. Interestingly, during previous structural analyses,
Gap always copurified with NAD+, which had to be removed
via activated charcoal to obtain the apoenzyme (57). In
contrast, the present Gap structure does not contain NAD+,
thus representing an apo form of the enzyme. Thus, H2O2
treatment seems to have led to loss of the coenzyme.
According to ourMS results and previous publications (73),
the Gap sulfonic acid was identified by MS as overoxidized
form. In the structure of overoxidized Gap, the sulfonic acid
form could be modeled into the electron density of the active
site Cys151 in each monomer (Supplementary Fig. S7B, C).
Overoxidation of Cys151 results in enzyme inhibition as sup-
ported by our activity assays. During catalysis, the sulfhydryl
group of Cys151 attacks the nucleophilic carbon of the G3P
substrate to form a covalent intermediate, thiohemiacetal (72).
In the active enzyme, His178 forms an ion pair with Cys151,
which increases the acidity and nucleophilicity of the thiol
group. DuringG3P oxidation, His178 hydrogen bondswith the
acyl carbonyl of the substrate and stabilizes the hemithioacetal
intermediate (57). Apart from interfering with the function of
Cys151, the sulfonyl moiety of the hyperoxidized Cys151 also
interacts with the main chain carbonyl of Asn316 and the im-
idazole ring of His178 (Fig. 9A; Supplementary Fig. S7D).
Thus, hyperoxidation ofCys151 affects the function of two key
catalytic residues of Gap, Cys151, and His178, leading to ir-
reversible inactivation of the enzyme.
To obtain insights into the structural changes upon S-
bacillithiolation, BSH was modeled into the active site of the
FIG. 9. Structural insights into the Gap active site after overoxidation and S-bacillithiolation. (A) Crystal structure
of the overoxidized active site Cys151 (Cys-SO3H, oC151) of Gap. (B, C) Computational model of BSH docked into the
active site of the Gap apoenzyme (B) and holoenzyme with the NAD+ coenzyme (C) using a covalent docking algorithm
that takes into account the possibility of bond formation between ligand and receptor. Shown is the best pose of 10 best
poses of the S-bacillithiolated active site. (D) Superposition of Gap-SO3H with the S-bacillithiolated apo- and holoenzyme
active sites. (E, F) The S-bacillithiolated active site pocket of the apoenzyme (E) and holoenzyme (F) structures rotated
by 25 over y axis in respect to (B, C). (G, H) Surface representation of apoenzyme (G) and holoenzyme (H) with
docked BSH.
PROTEIN S-BACILLITHIOLATION CONTROLS GAP ACTIVITY 423
apo- and holoenzyme structures using molecular docking
(Fig. 9B, C). We used a covalent docking algorithm that takes
into account the possibility of bond formation between ligand
and receptor. Docking of BSH into the apo- or holoenzyme
structure resulted in a set of covalent complexes (10 best po-
ses), in which the disulfide bond can readily form and which
are structurally very similar at least in the vicinity of the dis-
ulfide bond, suggesting a high confidence in the docking pose
(Supplementary Fig. S8). In the holoenzyme structure, the
NAD+ cofactor partially occludes the binding pocket and
narrows the space available for BSH binding. As a result, in the
holo-Gap active site, where NAD+ is present, BSH takes up
conformations, which differ significantly less compared with
the ones in the apoenzyme. When superimposing the two best
binding poses, BSH in the apoenzyme structure partially oc-
cupies the part of the pocket where NAD+ would be present
(Fig. 9D). However, in both cases, S-bacillithiolation of the
active site does not require major conformational changes of
the protein (Fig. 9E–H). In addition, previous molecular dy-
namic simulations of human GAPDH (61) suggested little
fluctuations of the protein. Taken together, we suggest that
BSH can undergo disulfide formation with the active site at
little energetic or entropic costs. This may further explain why
Gap as the most abundant redox-sensitive protein in the pro-
teome of S. aureus is also the most abundant S-bacillithiolated
protein under NaOCl stress.
Discussion
Dynamic thiol redox switches are the hallmarks of oxi-
dative stress response and the major principle of redox sig-
naling mechanism in prokaryotes and eukaryotes (33).
Quantitative redox proteomic methods such as OxICAT al-
low to determine the redox state of proteins thiols and to
dissect redox-sensitive thiols at high resolution (9, 48). To
date, global thiol redox proteomics in the major pathogen S.
aureus identified only few targets for oxidation under H2O2
stress (19, 77). However, S. aureus shows remarkable resis-
tance to 100mM H2O2, which is attributed to the constitutive
expression of the catalase KatA indicating that S. aureus is
well adapted to peroxide stress during infections (36).
In this study, we used OxICAT to monitor the redox state
of 228 Cys residues in S. aureus USA300 under more severe
infection-like conditions as provoked by hypochlorite. In
untreated cells, the majority of thiols (84.6%) are reduced
with an oxidation degree <25%, which is in agreement with
previous studies in E. coli and yeast cells (9, 48). Under
NaOCl stress, 58 NaOCl-sensitive proteins showed >10%
increased oxidation, indicating that 25% of all identified
protein thiols are redox sensitive in S. aureus. To analyze
whether these NaOCl-sensitive Cys residues are buried or
surface exposed, we calculated their relative surface acces-
sibilities (RSAs) using NetSurfP (www.cbs.dtu.dk/services/
NetSurfP/). However, only 9 of 228 Cys residues have RSA
values of >30% and are predicted as solvent exposed (Table 2
and Supplementary Table S1). The RSA calculations clearly
indicate that NaOCl-sensitive Cys residues are often the ac-
tive site centers that are not surface exposed and buried in the
predicted secondary protein structure.
Among the NaOCl-sensitive proteins with the highest
oxidation increase of 20–30%, we identified Gap, AldA, and
GuaB as S-bacillithiolated at their conserved substrate-
binding active sites. Only a few S-bacillithiolated proteins
were found by the shotgun proteomic approach due to the
instability and low abundance of the BSH-modified peptides.
Thus, we assume that many more NaOCl-sensitive proteins
of our OxICAT dataset are modified by S-bacillithiolation,
but failed to be identified using the shotgun method.
Apart from S-bacillithiolation, also alternative S-thiolations
are possible in S. aureus under NaOCl stress such as S-
cysteinylation or CoASH mixed disulfides since cysteine and
CoASH are also present in the thiol metabolome of S. aureus
(58, 64). Moreover, the Cdr displayed an increased oxidation
level under NaOCl stress at its conserved Cys16 in our OxI-
CAT analyses and was previously shown to function in re-
duction of CoASH disulfides in S. aureus (18, 55). However,
S-cysteinylation and CoASH mixed disulfides were not de-
tected by MS due to their low abundance or instability.
Many Zn-containing NaOCl-sensitive proteins were iden-
tified, such as the Fur repressor, which is oxidized in its
Zn-binding site. Zn-binding sites are common redox switch
motifs (37). The best-studied example is the oxidation-
sensitive Hsp33 chaperone that responds to hypochlorite by a
redox switch in its Zn motif and protects E. coli proteins
against oxidative aggregation (26, 38, 46). NaOCl-sensitive
Zn-containing proteins include the alcohol dehydrogenase
Adh and the ribosomal proteins, RpmG3 and RpmJ. Several
previously predicted redox-sensitive Cys residues are found in
CxxC motifs, such as the copper chaperone, CopZ, and the
antioxidant proteins, AhpC, TrxB, and ArsC (21). These re-
sults are in agreement with previous redox proteomic results in
E. coli under NaOCl stress (48). Increased oxidation levels
were detected for both MarR/OhrR family regulators MgrA
and SarZ that are oxidized at their single Cys residues. Using
Northern blot analyses, we confirmed that SarZ oxidation leads
to derepression of transcription of the ohrA gene (USA300-
HOU_0835) in S. aureus. Thus, the OxICAT approach iden-
tified increased oxidation of both major thiol redox regulators
under NaOCl stress in S. aureus.
The most abundant S-bacillithiolated protein was the gly-
colytic Gap enzyme in S. aureus under NaOCl stress, which
was S-bacillithiolated at the active site Cys151. Gap is the
most abundant Cys-containing protein contributing 4% to the
total Cys proteome. The active site Cys is used for the nu-
cleophilic attack at the aldehyde group of the G3P substrate to
catalyze the substrate-level phosphorylation of G3P to 1,3-
bisphosphoglycerate with production of NADH (34). Gap
homologs are common targets for oxidation in eukaryotes and
prokaryotes and subject of different post-translational thiol
modifications, including S-sulfenylation, S-glutathionylation,
S-nitrosylation, and S-sulfhydration, resulting in reversible en-
zyme inactivation (10, 34). Inactivation of Gap has been shown
to redirect the glycolytic flux into the pentose phosphate path-
way to supply nicotinamide adenine dinucleotide phosphate
(NADPH) as reducing power under oxidative stress (10, 66).
Gap of S. aureus was previously identified as oxidation-
sensitive target for reversible thiol modification (19) and was
also found to be overoxidized at its active site Cys151 under
H2O2 stress (73). Using biochemistry, MS, and X-ray crys-
tallography, we confirmed previous findings that the glyco-
lytic Gap enzyme from S. aureus is highly sensitive to
overoxidation to Cys sulfonic acid in vitro in the presence of
H2O2 alone. In this work, we found that Gap is the most
abundant S-bacillithiolated protein under NaOCl stress
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in vivo. We further demonstrate that S-bacillithiolation func-
tions in reversible inhibition of Gap activity under H2O2 and
NaOCl treatment in vitro and protects the active site Cys
against overoxidation to ensure fast regeneration of this es-
sential glycolytic enzyme during recovery of cells. Our Gap
activity assays suggest that both pathways, the overoxidation
and S-bacillithiolation, operate at similar kinetics under H2O2
treatment, while inactivation due to S-bacillithiolation was
faster under NaOCl stress. Together, our results confirm the
preference for formation of S-thiolation in the presence of
LMW thiols as observed in many eukaryotic Gap homologs
(34, 43, 78).
The reactivity of the active site cysteine toward H2O2 and
the substrate G3P was recently shown to depend on two
different mechanisms (34, 61). The catalytic Cys is in close
proximity with His178 in the structure of Gap of S. aureus
that attracts the thiol proton, leading to deprotonation and
increased acidity of the catalytic Cys. The acidic nature
explains the reactivity of catalytic Cys toward the substrate
G3P that covalently reacts with the nucleophilic thiolate
during the catalytic cycle (34, 62). However, the increased
acidity of Cys151 does not explain its strong reactivity to-
ward H2O2. Instead, the reactivity of the active site thiolate
depends on a specific H2O2-binding pocket, transition state
stabilization, and a proton relay mechanism promoting
leaving group departure (34, 61).
This proton relay mechanism also determines the preferred
modification by S-bacillithiolation of Gap in S. aureus under
H2O2 in vitro, which requires the initial formation of a sul-
fenic acid, followed by reaction to the BSH mixed disulfide.
HOCl shows very fast reaction rates with thiols (3· 107
M-1s-1) that are several orders of magnitude higher com-
pared with H2O2 (17, 27, 30, 60, 74). HOCl first leads to
chlorination of thiols resulting in an unstable sulfenylchloride
intermediate that reacts further to form disulfides in the
presence of another thiol. In the absence of proximal thiols,
the sulfenylchloride quickly leads to irreversible oxidation
stages (17, 30, 52). We have shown in S. aureus that S-
bacillithiolation functions in protection and redox regulation
of the Gap active site against overoxidation under NaOCl
stress in vitro and in vivo. Molecular docking of BSH into the
active site of the Gap apo- and holoenzyme was used to
model the S-bacillithiolated active site at high confidence.
The model of Gap-SSB structure suggests that BSH can un-
dergo disulfide formation with Cys151 without major con-
formational changes. This may explain why the most
abundant Cys protein Gap is the preferred and dominant
target for S-bacillithiolation inside S. aureus cells.
S-glutathionylation of the active site Cys of Gap was
found in many eukaryotic organisms, such as Arabidopsis
thaliana, the malaria parasite Plasmodium falciparum, or in
human endothelial cells, leading to reversible inhibition of
Gap activity (3, 43, 69). Reactivation of Gap was catalyzed
by glutaredoxins and thioredoxins in plants and malaria
parasites (3, 43). In B. subtilis, the bacilliredoxins, BrxA
and BrxB, were shown to catalyze the reduction of S-
bacillithiolated OhrR and MetE in vitro (24). In this study,
we showed that S-bacillithiolated Gap is also a substrate for
the bacilliredoxin Brx (SAUSA300_1321) in S. aureus,
which requires the active site Cys for debacillithiolation
in vitro. Thus, the bacilliredoxin pathway is also involved in
regeneration of Gap activity in S. aureus.
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains usedwere S. aureusCOL and USA300 and
its isogenic bshA mutants as described previously (64). For
cloning and genetic manipulation, E. coli DH5a and BL21
(DE3) plysS were cultivated in Luria Bertani (LB) medium.
For NaOCl stress experiments, S. aureus USA300 and COL
strains were cultivated in LB medium until an optical density
at 540 nm (OD540) of 2.0, transferred to Belitsky minimal
medium, and treated with 150lM NaOCl stress as described
(51). NaOCl, diamide, DTT, N-ethylmaleimide (NEM), and
H2O2 (35% w/v) were purchased from Sigma-Aldrich.
MS-based thiol redox proteomics
using the OxICAT approach
S. aureusUSA300was harvested before and after exposure
to 150 lM NaOCl for 30min, respectively. The OxICAT
method was performed according to the protocol of Linde-
mann and Leichert (49) with the modification that cells were
disrupted using a ribolyzer. The ICAT-labeled peptides were
dissolved in 0.1% (v/v) acetic acid and loaded onto self-
packed LC columns with 10ll of buffer A (0.1% (v/v) acetic
acid) at a constant pressure of 220 bar without trapping.
Peptides were eluted using a nonlinear 85-min gradient from
1% to 99% buffer B (0.1% (v/v) acetic acid in acetonitrile)
with a constant flow rate of 300 nl/min and measured using
Orbitrap MS as described (6). The S. aureus USA300 se-
quence database was extracted from Uniprot and used by the
search engine Andromeda and the MaxQuant software (ver-
sion 1.5.1.2) to quantify the ICAT-labeled Cys peptides. Two
miscleavages were allowed, the parent ion mass tolerance
was 10 ppm and the fragment ion mass tolerance was 1.00
Da. The average percentage of oxidation of each Cys peptide
and the percentage change under NaOCl stress were calcu-
lated from 2 to 3 biological replicates using the intensity
values provided by MaxQuant. Voronoi treemaps were
generated using the Paver software to visualize the percent-
age oxidation of all identified ICAT-labeled peptide pairs.
The OxICAT proteomic data have been deposited to the
ProteomeXchange Consortium via the PRIDE partner re-
pository with the dataset identifier PXD004918.
Identification of S-bacillithiolated and overoxidized
Cys peptides using LTQ-Orbitrap MS
For identification of S-bacillithiolated peptides, NEM-
alkylated protein extracts were prepared from S. aureus
USA300 cells after exposure to 150lM NaOCl for 30min as
described (15). The protein extracts were separated by 15%
nonreducing sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE), followed by tryptic in-gel di-
gestion and LTQ-Orbitrap-VelosMS, as described (15). Post-
translational thiol modifications of proteins were identified
by searching all tandem mass spectrometry (MS/MS) spectra
in dta format against the S. aureus USA300 target–decoy
protein sequence database extracted from UniprotKB release
12.7 (UniProt Consortium, Nucleic acids research 2007, 35,
D193-197) using Sorcerer-SEQUEST (Sequest v. 2.7 rev.
11, Thermo Electron, including Scaffold 4.0; Proteome
Software, Inc., Portland, OR). The SEQUEST search para-
meters and thiol modifications were used as described (15).
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The scores and mass deviations of the S-bacillithiolated
peptides are shown in detail in Supplementary Figure S1,
including their fragmentation spectrum and ion tables.
MS of the H2O2-treated overoxidized Gap was performed
after in-gel tryptic digestion using nLC-MS/MS by Orbitrap
fusion, as described previously (45). For Cys151-SO3H
peptide identification and quantification, MS1 data were fil-
tered to the precursor target masses applying an m/z window
of 3 ppm. Isotopic distribution and fragmentation spectra
were inspected manually in different charge states in suc-
cessive MS2 scans in different overoxidized Gap samples.
Cloning, expression, and purification of the S. aureus
Gap, Brx, and Brx Cys-Ala mutant proteins in E. coli
The previously constructed plasmids, pET11b-Brx-roGFP2,
pET11b-BrxAGC-roGFP2, and pET11b-BrxCGA-roGFP2 (51),
were used as template to amplify S. aureus brx (SAUSA300_
1321), brxAGC, and brxCGA by PCR using primer pairs 1321-
roGFP2-For-NheI (5¢-CTAGCTAGCATGAATGCATATGAT
GCTTATATGAAAG-3¢) and roGFP2-1321-Rev-BamHI (5¢-
CGCGGATCCTTAGTGATGGTGATGGTGATGTTTACAA
TTTTCGTCAAAGGC-3¢). The reverse primer also encodes the
C-terminal His6-tag. The PCR products were digested withNheI
and BamHI and inserted into plasmid pET11b (Novagen) that
was digested using the same restriction enzymes to generate
plasmids pET11b-brx, pET11b-brxAGC, and pET11b-brxCGA.
The primer pairs gap-For-NdeI (5¢-GGAATTCCATATGGCA
GTAAAAGTAGCAATTAATG-3¢) and gap-Rev-BamHI (5¢-
CGCGGATCCTTAGTGATGGTGATGGTGATGTTTAGAA
AGTTCAGCTAAGTATGC-3¢) were used to amplify the
S. aureus gap gene (SAUSA300_0756) by PCR. Chromo-
somal DNA of S. aureusUSA300 was used as template. The
PCR products were digested with the restriction enzymes,
NdeI and BamHI, and inserted into plasmid pET11b that
was digested with the same enzymes to generate plasmids
pET11b-gap. The correct sequences of the cloned genes
were confirmed by sequencing. The plasmids were trans-
formed into E. coli BL21 (DE3) plysS (Novagen).
For protein expression, E. coli BL21(DE3) plysS strains
with the plasmids, pET11b-gap, pET11-brx, pET11b-brxAGC,
and pET11b-brxCGA, were grown in 1 liter LB medium and
1mM isopropyl-b-D-thiogalactopyranoside (IPTG)was added
at the exponential phase (OD600 of 0.8) for 3 h at 37C. His-
tagged proteins were purified using His Trap HP Ni-NTA
columns and the A¨KTA purifier liquid chromatography system
(Amersham Bioscience). The proteins were further concen-
trated to 2–6mg/ml using Amicon Ultra concentrators (Mil-
lipore). Before the activity assays, Gap and Brx proteins were
reduced with 10mM DTT for 30min, followed by DTT re-
moval using Micro Biospin 6 columns (Biorad).
Gap activity assay
Gap activity was monitored spectrophotometrically at
340 nm and 25C by the production of NADH. The oxidation
of G3P to 1,3-bisphosphoglycerate (1,3-BPG) was measured
in an assay mixture containing 1.25mM NAD+ and 0.25 lM
Gap in argon-flushed 20mM Tris-HCl, pH 8.7, with 1.25mM
ethylenediaminetetraacetic acid and 15mM sodium arsenate.
After preincubation, the reaction was started by addition of
0.25mM D,L-G3P. Sodium arsenate was used as a cosub-
strate to form unstable 1-arseno-3-phosphoglycerate, as de-
scribed previously (61). Degradation of the product allows a
favorable equilibrium for measuring the rate of Gap activity
in the glycolytic forward reaction. Initial rates were deter-
mined by calculation of the slope in the linear part of the
curve during the first 80 seconds at the beginning of the
reaction (linear regression function, GraphPad) as described
previously (61). Percentage of Gap activity was calculated as
(Rateinactivated/Rateuntreated x 100%). The results are presented
as mean – SEM from at least three separate experiments.
S-bacillithiolation of Gap in vitro and reduction
by the bacilliredoxin Brx
About 25lM of purified Gap was S-bacillithiolated with
250 lM BSH in the presence of 2.5mM H2O2 for 5min.
Excess of BSH and H2O2 was removed with Micro Biospin 6
columns (Biorad). For the Brx debacillithiolation assay, Gap-
SSB was incubated with Brx, BrxCGA, and BrxAGC at 37C
for 30min, followed by Gap activity assays and nonreducing
BSH-specific Western blot analysis, as described (16).
Western blot analysis
The S-bacillithiolated proteins were harvested from S.
aureus USA300 wild-type and bshA mutant cells after ex-
posure to 150 lM NaOCl, separated by nonreducing SDS-
PAGE, and subjected to BSH-specific Western blot analysis
using the polyclonal rabbit anti-BSH antiserum, as described
previously (16).
Northern blot experiments
Northern blot analyses were performed as described before
(15) using RNA isolated from S. aureus USA300 wild type
under control conditions and after treatment with 150lM
NaOCl. Hybridization specific for ohrA (USA300HOU_0835)
was performed with the digoxigenin-labeled RNA probe syn-
thesized in vitro using T7 RNA polymerase from T7 promoter
containing internal PCR products using the primer pairs
ohrA-for, 5¢ TGGCAATACATTATGAAACTAAAGC 3¢,
and ohrA-T7-rev, 5¢ CTAATACGACTCACTATAGGGAGA
TTTAAATCGACATTAATATTTCCTTGA 3¢.
Crystallographic procedures
Before crystallization, H2O2-treated overoxidized Gap
was concentrated to 11mg/ml. Crystals of overoxidized Gap
were grown at 18C using the hanging drop vapor diffusion
technique and 30% (w/v) PEG 3350, 0.1 M Tris, pH 8.5, as
the reservoir solution. Crystals were cryoprotected by trans-
fer into mother liquor mixed with 50% (v/v) PEG 400 in a 1:1
ratio and flash-cooled in liquid nitrogen. X-ray diffraction
data were collected from a single crystal at 100 K on beam-
line 14.1 of the BESSY II storage ring (Berlin, Germany) (56)
equipped with a PILATUS 6M detector (Company-REF),
with a 0.1  oscillation and exposure time of 0.3 s per frame.
Diffraction images were processed using XDS (41). Crystal
parameters and data collection statistics are given in Sup-
plementary Table S3. The Gap-SO3H structure was solved
by molecular replacement with Molrep (71) using the struc-
ture of the Gap apoenzyme (PDB entry 3LC7; [57]) as a
model. The final model of the Gap-SO3H was generated by
iterative rounds of manual model building using Coot (20)
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and automated refinement using the phenix.refine package in
PHENIX (1) with the inclusion of TLS parameters generated
by the TLSMD server (59). Coordinates and structure factor
amplitudes have been deposited in the Protein Data Bank (4)
under the accession code 5T73 and will be released upon
publication.
Molecular docking of BSH into the Gap active site
To model a covalent complex between BSH and the S.
aureus Gap active site Cys151, docking experiments were
performed with the holo form containing NAD [PDB code:
3LVF chain R, (57)] as well as the apo form [PDB code: 3LC7
chain O, (57)] of the enzyme. Before molecular docking, both
protein structures were prepared using the protein preparation
wizard (68) in the Schrodinger software (Release 2016–1)
graphical user interface Maestro. Hydrogen was added ac-
cording to the protonation states at pH of 7.0 as predicted by
PROPKA, bond orders were assigned, and disulfide bonds
were allocated. Water with less than three hydrogen bonds to
nonwater residues was removed and minimization of heavy
atoms was performed using OPLS3. The BSH structure was
obtained from Pubchem (ID: CID 42614123) and processed
with the ligand preparation wizard. The ligand was protonated
at pH of 7.0– 2.0 using Epik (28). Covalent molecular docking
was performed using CovDock (79), which combines the two
programs Glide (23) for docking and Prime (39, 40) for min-
imization. Cysteine 151 was set as reactive residue, and the
reaction type was disulfide formation. All atom positions were
fixed, except for the targeted residue and the ligand. Covalent
docking was performed with default options and the poses
were ranked according to the Prime energy.
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Abbreviations Used
1,3-BPG¼ 1,3-bis-phosphoglycerate
BrxAGC¼ bacilliredoxin active site mutant
BrxCGA¼ bacilliredoxin resolving Cys mutant
BSH¼ bacillithiol
bshA¼ gene for BSH glycosyltransferase
BSSB¼ oxidized bacillithiol disulfide
Cdr¼CoASH disulfide reductase
CoASH¼ coenzymeA
CV¼ coefficient of variation
Cys¼ cysteine
DTT¼ dithiothreitol
EDTA¼ ethylenediaminetetraacetic acid
G3P¼ glyceraldehyde-3-phosphate
Gap¼ glyceraldehyde-3-phosphate
dehydrogenase
Gap-SO3H¼Gap sulfonic acid
Gap-SSB¼ S-bacillithiolated Gap
GlcNAc¼N-acetyl glucoseamine
H2O2¼ hydrogen peroxide
HOCl¼ hypochlorous acid
ICAT¼ isotope-coded affinity tag
IMP¼ inosine 5¢-monophosphate
IPTG¼ isopropyl-b-D-thiogalactopyranoside
LB¼Luria bertani
LC¼ liquid chromatography
LMW¼ low-molecular-weight
LTQ¼ linear trap quadrupole
Mal¼malate
Met¼methionine
MPO¼myeloperoxidase
MRSA¼methicillin-resistant
Staphylococcus aureus
Mrx1¼mycoredoxin1
MS¼mass spectrometry
MS/MS¼ tandem mass spectrometry
NADH¼ nicotinamide adenine dinucleotide
NADPH¼ nicotinamide adenine dinucleotide
phosphate
NaOCl¼ sodium hypochlorite
NEM¼N-ethylmaleimide
OxICAT¼ thiol redox proteomic methods based
on the differential labeling of reduced
Cys residues with light ICAT and
of reversibly oxidized Cys residues
with heavy ICAT after reduction
using TCEP
protein-SSB¼BSH protein mixed disulfide
RNS¼ reactive nitrogen species
roGFP2¼ redox-sensitive green fluorescent
protein
ROS¼ reactive oxygen species
RSA¼ relative surface accessibility
SDS-PAGE¼ sodium dodecyl sulfate–polyacrylamide
gel electrophoresis
TCEP¼Tris (2-carboxyethyl) phosphine
Trx¼ thioredoxin
TrxR¼ thioredoxin reductase
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